The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Indicators of Prognosis in Node-Negative Breast Cancer
Open accessAbstract
Measures of the proliferative activity of tumor cells have prognostic value in patients with node-negative breast cancer. We studied 367 women in southern Sweden who had undergone surgical resection for such cancer. Tumor specimens were analyzed with DNA flow cytometry in order to estimate both the DNA content (ploidy) and the fraction of cells in the synthetic phase of the cell cycle (S phase). The median duration of follow-up was four years; 28 percent of the patients received adjuvant therapy, usually with tamoxifen (n = 83). A multivariate analysis based on complete data on 250 patients included the following covariates: age (greater than or equal to 75, 50 to 74, and less than or equal to 49 years), tumor size (less than or equal to 20 vs. greater than 20 mm), concentration of estrogen and progesterone receptors (less than 10 vs. greater than or equal to 10 fmol per milligram of protein), ploidy (diploid vs. nondiploid), and S-phase category (fraction of cells in S phase: less than 7.0 percent, 7.0 to 11.9 percent, and greater than or equal to 12 percent). The S-phase fraction yielded the most prognostic information, followed by progesterone-receptor status and tumor size. A prognostic model based on these three variables identified 37 percent of the patients as constituting a high-risk group with a fourfold increased risk of distant recurrence. In the remaining 63 percent of the patients, the five-year overall survival rate (92 +/- 4 [+/- SE] percent) did not differ from the expected age-adjusted rate for Swedish women. We conclude that a prognostic index that includes indicators of the proliferative activity of tumor cells may be able to identify women with node-negative breast cancer in whom the risk of recurrence is sufficiently low that adjuvant chemotherapy can be avoided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
Andersson, I., Aspegren, K., Janzon, L., Landberg, T., Lindholm, K., Linell, F., Ljungberg, O., Ranstam, J., & Sigfússon, B. (1988) · BMJ · doi:10.1136/bmj.297.6654.943 · Cited by 916
Convention on nomenclature for DNA cytometry
Hiddemann, W., Schumann, J., Andreeff, M., Barlogie, B., Herman, C. J., Leif, R. C., Mayall, B. H., Murphy, R. F., & Sandberg, A. A. (1984) · Cytometry · doi:10.1002/cyto.990050502 · Cited by 586
Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow Cytometry
Clark, G. M., Dressler, L. G., Owens, M. A., Pounds, G., Oldaker, T., & McGuire, W. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903093201003 · Cited by 558
Cancer of the breast: Size of neoplasm and prognosis
Fisher, B., Slack, N. H., Bross, I. D. F., & Cooperating Investigators (1969) · Cancer · doi:10.1002/1097-0142(196911)24:5<1071::aid-cncr2820240533>3.0.co;2-h · Cited by 486
Cancer of the Breast: The Past Decade
Henderson, I. C., & Canellos, G. P. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001033020104 · Cited by 467
Fisher, B., Redmond, C., Fisher, E. R., & Caplan, R. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.7.1076 · Cited by 419
Cited by
Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
Heagerty, P. J., Lumley, T., & Pepe, M. S. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00337.x · Cited by 2,854
Jänicke, F., Schmitt, M., Pache, L., Ulm, K., Harbeck, N., Höfler, H., & Graeff, H. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf01833260 · Cited by 355
Kallioniemi, O., Holli, K., Visakorpi, T., Koivula, T., Helin, H. H., & Isola, J. J. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490504 · Cited by 346
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
Colozza, M., Azambuja, E., Cardoso, F., Sotiriou, C., Larsimont, D., & Piccart, M. J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi352 · Cited by 307
Prognostic Factors and Treatment Decisions in Axillary-Node-Negative Breast Cancer
Desforges, J. F., McGuire, W. L., & Clark, G. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262607 · Cited by 282
Metadata
- Authors
- Sigurdsson, H., Baldetorp, B., Borg, Å., Dalberg, M., Fernö, M., Killander, D., & Olsson, H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1990-04-12
- Volume
- 322
- Issue
- 15
- Pages
- 1045-1053
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2341230536
- Cited by
- 337
- References
- 16
- FWCI
- 20.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Indicators of Prognosis in Node-Negative Breast Cancer. https://app.cochat.ai/papers/10.1056/nejm199004123221505
- The paper
- Sigurdsson, H., Baldetorp, B., Borg, Å., Dalberg, M., Fernö, M., Killander, D., & Olsson, H. (1990). Indicators of Prognosis in Node-Negative Breast Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejm199004123221505
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.